Predictors of Vedolizumab Treatment Persistence in Bio-Naïve Ulcerative Colitis Patients

February 12, 2020

Timothy E. Ritter – GI Alliance, Southlake, TX
Harry E. Sarles – Digestive Health Associates of Texas, Dallas, TX
Samantha A. Mehta – Healix Infusion Therapy, Sugar Land, TX
Lucinda J. Van Anglen – Healix Infusion Therapy, Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.